Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.